Decitabine 20 mg/m²/day for 5 days

DRUG3 trials

Sponsors

Chinese PLA General Hospital, The Methodist Hospital Research Institute, The First Affiliated Hospital of Soochow University

Conditions

AMLAcute Myeloid Leukaemia (AML)Acute Myeloid Leukemia (AML)Hematopoietic Stem Cell Transplantation (HSCT)Leukemia, Myeloid, Acute(AML)

Phase 2

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

CompletedNCT02662647

Chinese PLA General HospitalAML

Start: 2015-04-30End: 2019-03-31Updated: 2019-06-10

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

Not yet recruitingNCT07060001

The Methodist Hospital Research InstituteAcute Myeloid Leukemia (AML), Acute Myeloid Leukaemia (AML)

Start: 2026-04-01End: 2029-12-01Target: 112Updated: 2026-03-06

Unknown Phase

A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients

Not yet recruitingNCT07762508

The First Affiliated Hospital of Soochow UniversityLeukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT)

Start: 2026-08-01End: 2029-07-01Target: 42Updated: 2026-08-19